USPTO trademark

CHRYSALIN

RegisteredUSPTOWord markClass 5

"CHRYSALIN" is a word mark owned by Chrysalis BioTherapeutics, Inc., filed at the USPTO on September 9, 2020. It is registered and covers class 5 (Pharmaceuticals).

Get this data via the API

Data current as of September 17, 2024Official USPTO record

As filed with the USPTO

Status: Registered; Since September 17, 2024
Filed: September 9, 2020
Registered: September 17, 2024
Expires: Not recorded
Application no.: 90169585
Registration no.: 7507922
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns CHRYSALIN

The owner and representative on file with the office.

Owner

Chrysalis BioTherapeutics, Inc.

Galveston, United States

Representative

Shannon T. Vale

Pirkey Barber PLLC

Goods and services

What the mark covers

The products and services CHRYSALIN is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetic foot ulcers; Pharmaceutical preparations for accelerating healing of human tissue; Therapeutic gels intended for topical use on skin and mucous membranes, intended to accelerate the healing of skin surface wounds and diabetic foot ulcers; Pharmaceuticals for the treatment of acute radiation syndrome; Pharmaceuticals for the treatment of COVID-19; Pharmaceutical products for the prevention and treatment of Degenerative Brain Diseases and Traumatic Brain Injury (TBI)

History

What has happened so far

Steps recorded by the USPTO, newest first.

September 17, 2024Notice of registration confirmation emailed
September 17, 2024Registered-principal register
August 11, 2024Notice of acceptance of statement of use e-mailed
August 11, 2024Allowed principal register - sou accepted
July 19, 2024Statement of use processing complete
July 19, 2024Case assigned to intent to use paralegal
June 5, 2024Use amendment filed
June 5, 2024Teas statement of use received
December 1, 2023Notice of approval of extension request e-mailed
November 30, 2023Sou extension 5 granted

10 earlier steps on the official record.

FAQ

About CHRYSALIN

Who owns the trademark "CHRYSALIN"?

The USPTO trademark "CHRYSALIN" (application 90169585) is owned by Chrysalis BioTherapeutics, Inc.

What is the status of "CHRYSALIN"?

Its status at the USPTO is: registered.

When was "CHRYSALIN" registered?

It was registered on September 17, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CHRYSALIN and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2c37-23ec-754f-8b0e-81d2811203dd
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2c37-23ec-754f-8b0e-81d2811203dd",
  "object": "trademark",
  "mark_text": "CHRYSALIN",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "90169585",
  "filing_date": "2020-09-09",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Chrysalis BioTherapeutics, Inc.",
      "entity_id": null
    }
  ]
}